Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
BacoCure
BacoCure Overview
BacoCure is developing a novel bacterial product for local therapy (intravesicular) of patients with non-muscle invasive bladder cancer. BacoCure's lead product is a novel mutated and inactivated uropathogenic bacteria that has demonstrated impressive anti-tumor effects via a novel and differentiated mechanism of action with a better safety profile compared to Bacillus Calmette-Guerin. The product is at an advanced preclinical development stage.